British journal of obstetrics and gynaecology

Br J Obstet Gynaecol · ISSN (print) 0306-5456 · 223 papers in corpus
case-report 1996
doi:10.1111/j.1471-0528.1996.tb09639.x ·PMID:8968246
nonrandomized-trial 1996
doi:10.1111/j.1471-0528.1996.tb09667.x ·PMID:8616132

OBJECTIVE: To assess whether suppression of ovarian function by a gonadotrophin releasing hormone (GnRH) analogue could assist in the diagnosis of chronic pelvic pain in women with residual ovaries. DESIGN: Uncontrolled, observational stud…

other 1996
doi:10.1111/j.1471-0528.1996.tb09770.x ·PMID:8624317

OBJECTIVE: To study the potential for dissemination of endometrial tissue substances during transcervical resection of the endometrium (TCRE). DESIGN: Prospective study. SETTING: One university and two county hospitals. PARTICIPANTS: For…

rct 1996
·PMID:8916982

Add-back hormone replacement therapy has been shown to alleviate some of the hypo-oestrogenic side effects associated with gonadotrophin-releasing hormone agonists, including demineralisation of bone. Studies on patients with uterine fibroi…

review 1996
doi:10.1111/j.1471-0528.1996.tb09543.x ·PMID:8863691
rct 1996
doi:10.1111/j.1471-0528.1996.tb09746.x ·PMID:8605138
rct 1996
doi:10.1111/j.1471-0528.1996.tb09506.x ·PMID:8916978

The usefulness of the gonadotrophin-releasing hormone (GnRH) agonists in treating benign chronic gynaecological disorders, such as endometriosis and uterine fibroids, or pre-menstrual syndrome (PMS), is limited by their hypo-oestrogenic sid…

rct 1996
doi:10.1111/j.1471-0528.1996.tb09807.x ·PMID:8645650

OBJECTIVES: To ascertain whether treatment with a gonadotrophin releasing hormone agonist before endometrial resection reduces absorption of distension fluid and operating time and facilitates the procedure. DESIGN: A multicentre, prospect…

other 1995
doi:10.1111/j.1471-0528.1995.tb10889.x ·PMID:8534637
diagnostic-accuracy 1995
doi:10.1111/j.1471-0528.1995.tb11320.x ·PMID:7632639

OBJECTIVE: To evaluate prospectively the role of endovaginal ultrasonography in the diagnosis of adenomyosis and to identify predictive characteristics. SETTING: In Vitro Fertilisation Unit, Hammersmith Hospital. SUBJECTS: Fifty-six women…

rct 1995
doi:10.1111/j.1471-0528.1995.tb09159.x ·PMID:7577853

The medium- and long-term effects of gestrinone and danazol on the endometrium were examined in 36 patients with endometriosis. Endometrial biopsies were taken from each patient before treatment and after 3 and 6 months of treatment with 60…

review 1995
doi:10.1111/j.1471-0528.1995.tb09158.x ·PMID:7577852

The treatment approach towards endometriosis has been traditionally either surgical or hormonal in nature. Since endometriosis is, to a large extent, a microscopic disease, a surgical approach cannot be expected to eradicate the disease. Tr…

other 1995
doi:10.1111/j.1471-0528.1995.tb09148.x ·PMID:7612522
review 1995
doi:10.1111/j.1471-0528.1995.tb09139.x ·PMID:7612516

OBJECTIVE: To provide a statistically integrated analysis and review of all published outcome studies of in vitro fertilisation (IVF) and gamete intrafallopian transfer (GIFT) occurring in English language journals between 1987 and 1992; to…

other 1995
doi:10.1111/j.1471-0528.1995.tb11330.x ·PMID:7632649
other 1995
doi:10.1111/j.1471-0528.1995.tb10909.x ·PMID:8652464
review 1995
doi:10.1111/j.1471-0528.1995.tb09157.x ·PMID:7577851

Endometriosis may result in pain and/or infertility in some patients, while others may remain asymptomatic. The disease appears to progress and regress somewhat unpredictably, making it difficult to determine the appropriate treatment. Prog…

rct 1995
doi:10.1111/j.1471-0528.1995.tb10853.x ·PMID:7547744
case-report 1995
doi:10.1111/j.1471-0528.1995.tb11297.x ·PMID:7612539
rct 1995
doi:10.1111/j.1471-0528.1995.tb09161.x ·PMID:7577850

In an open-label, multicentre, randomized, parallel group study, 164 women with endometriosis were assigned to treatment. Out of these women, 81 received danazol (600 mg daily for 8 weeks, then 400 mg for 16 weeks) and 83 were given gestrin…

rct 1995
doi:10.1111/j.1471-0528.1995.tb09160.x ·PMID:7577849

In a large, double-blind, multicentre study, 269 patients with confirmed endometriosis were randomly allocated to receive either danazol (200 mg twice daily; n = 137) or gestrinone (2.5 mg twice weekly; n = 132) for 6 months. The two groups…

case-report 1994
doi:10.1111/j.1471-0528.1994.tb13628.x ·PMID:8199087
other 1994
doi:10.1111/j.1471-0528.1994.tb13677.x ·PMID:8199099
review 1994
doi:10.1111/j.1471-0528.1994.tb13690.x ·PMID:8043556

Although usually not life-threatening, dysfunctional uterine bleeding (DUB) can cause discomfort and disruption to life for many women. It has been poorly researched in the past, primarily because of difficulties in trying to accurately mea…

case-report 1994
doi:10.1111/j.1471-0528.1994.tb13627.x ·PMID:8199086